<DOC>
	<DOCNO>NCT00283023</DOCNO>
	<brief_summary>Recent development understand stem- progenitor cell differentiation raise hop brain damage chronic neurological disease may become repaired systemic focal transplantation cell . Clinical trial stem- progenitor cell transplantation multiple sclerosis currently premature . The researcher develop protocol human oligodendrocyte progenitor cell culture human brain treatment demyelinate disease .</brief_summary>
	<brief_title>Oligodendrocyte Progenitor Cell Culture From Human Brain</brief_title>
	<detailed_description>Oligodendrocyte progenitor cell line culture transplant patient Multiple sclerosis .</detailed_description>
	<mesh_term>Demyelinating Diseases</mesh_term>
	<criteria>Male female 2065 year age Informed consent Has elective craniotomy surgery HIV , hepatitis , central nervous system ( CNS ) infection Dementia , Alzheimer disease , neurodegenerative disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>All selective craniotomy</keyword>
</DOC>